Kaliumklorid Eql Pharma

Potassium Chloride, the active ingredient in Kaliumklorid Eql Pharma, is an electrolyte supplement presented as an oral formulation for oral use. It is used to treat hypokalemia and other potassium deficiency states in patients requiring potassium replacement. It helps restore normal serum potassium levels and supports cardiac and muscular function.

GNH USA supplies Kaliumklorid Eql Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory‑compliant documentation for importers.

Kaliumklorid Eql Pharma, an oral potassium chloride electrolyte supplement, is employed in conditions characterized by low serum potassium. - Hypokalemia: Restores serum potassium to normal range, reducing risk of cardiac and muscular complications. - Potassium deficiency: Provides potassium ions to correct chronic or acute deficits and maintain electrolyte balance. - Diuretic‑induced potassium loss: Supplements potassium to offset urinary losses associated with loop or thiazide diuretics.

Oral potassium chloride may be associated with several adverse reactions, ranging from mild gastrointestinal symptoms to rare but serious electrolyte disturbances.

Common Side Effects: - Nausea: Mild queasiness that may occur after ingestion. - Vomiting: Episodes of stomach emptying, especially with rapid dosing. - Abdominal discomfort: Cramping or pain in the stomach region. - Diarrhea: Loose stools that can result from irritation of the intestinal lining.

Serious or Rare Side Effects: - Hyperkalemia: Excessively high serum potassium that can cause cardiac rhythm abnormalities. - Cardiac arrhythmia: Irregular heartbeats potentially life‑threatening. - Severe allergic reaction: Rash, itching, swelling, or anaphylaxis in rare cases.

When prescribing or dispensing Kaliumklorid Eql Pharma, several precautions should be observed to ensure safe use. - Assess serum potassium: Verify baseline potassium level before initiating therapy. - Monitor renal function: Adjust dose or avoid use in patients with impaired kidney clearance. - Concomitant medications: Review use of ACE inhibitors, ARBs, or potassium‑sparing diuretics that may increase potassium. - Cardiovascular monitoring: Observe ECG for changes in patients at risk of arrhythmia. - Avoid in hyperkalemia: Do not administer if serum potassium is already elevated. - Store at ambient temperature: Keep below 25 °C, in the original packaging, protected from moisture.

Potassium chloride can interact with several drugs, altering potassium balance or cardiac risk.

Major Interactions (Avoid): - ACE inhibitors or ARBs: Combined use may cause dangerous hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): Increases risk of excessive potassium accumulation. - Sodium bicarbonate: Enhances potassium reabsorption, raising serum levels.

Moderate Interactions (Monitor Closely): - Digoxin: Elevated potassium can modify digoxin toxicity risk. - NSAIDs: May reduce renal potassium excretion, requiring monitoring. - Beta‑blockers: Can affect potassium distribution, necessitating periodic serum checks.